Crizotinib, an Effective Agent in ROS1-Rearranged Adenocarcinoma of Lungs: A Case Report

INTRODUCTION: ROS1 rearrangement has recently emerged as a new molecular subtype in non–small-cell lung cancer (NSCLC) and is predominantly found in lung adenocarcinoma compared with other oncogenes such as EGFR, KRAS, or ALK. It has been identified in only 1% to 2% of NSCLC cases. CASE REPORT: We r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Med Insights Case Rep
Hlavní autoři: Joshua, Julie Mariam, KD, Salima, K, Pavithran, Vijayan, Meenu
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2018
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5772496/
https://ncbi.nlm.nih.gov/pubmed/29371790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179547617749615
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky